3Divecha N, Irvine RF. Phospholipid signaling[J]. Cell, 1995 ,80(2):269-278.
4Kim H,McGrath BM,Silverstone PH. A review of thepossible relevance of inositol and the phosphatidylinositol secondmessenger system (PI -cycle ) to psychiatric disorders-focus onmagnetic resonance spectroscopy ( MRS ) studies [J]. HumanPsychopharmacology:Clinical and Experimental,2005,20 ( 5):309-326.
5Nikawa J -I, Tsukagoshi Y, Yamashita S. Isolation andcharacterization of two distinct myo-inositol transporter genes ofSaccharomyces cerevisiae [J]. Journal of Biological Chemistry,1991,266(17):11184-11191.
6Taylor M,Wilder H,Bhagwagar Z,et al. Inositol for depressivedisorders[J]. Cochrane Database of Systematic Reviews, 2004,2.
7Haroon E,Watari K,Thomas A,et al. Prefrontal myo-inositolconcentration and visuospatial functioning among diabeticdepressed patients[J]. Psychiatry Research : Neuroimaging, 2009,171(1):10-19.
8Vucenik I,Shamsuddin AM. Cancer inhibition by inositolhexaphosphate (IP6 ) and inositol : from laboratory to clinic [J].The Journal of nutrition,2003,133( 11): 3778S-3784S.
9Nishino H, Murakoshi M, Masuda M, et al. Suppression oflung and liver carcinogenesis in mice by oral administration ofmyo-inositol[J]. Anticancer research, 1998,19( 5A) : 3663—3664.
10Lamer J. D -chiro -inositol -its functional role in insulinaction and its deficit in insulin resistance [J]. ExperimentalDiabetes Research,2002,3(1): 47—60.
